Processa Pharmaceuticals Statistics

Total Valuation

PCSA has a market cap or net worth of $2.78 million. The enterprise value is -$17,718.

Market Cap	2.78M
Enterprise Value	-17,718

Important Dates

The last earnings date was Wednesday, October 30, 2024, after market close.

Earnings Date	Oct 30, 2024
Ex-Dividend Date	n/a

Share Statistics

PCSA has 3.27 million shares outstanding. The number of shares has increased by 117.51% in one year.

Current Share Class	3.27M
Shares Outstanding	3.27M
Shares Change (YoY)	+117.51%
Shares Change (QoQ)	+9.81%
Owned by Insiders (%)	5.81%
Owned by Institutions (%)	1.49%
Float	2.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.75
P/TBV Ratio	0.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.97, with a Debt / Equity ratio of 0.03.

Current Ratio	3.97
Quick Ratio	2.37
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -211.71% and return on invested capital (ROIC) is -132.05%.

Return on Equity (ROE)	-211.71%
Return on Assets (ROA)	-113.11%
Return on Capital (ROIC)	-132.05%
Revenue Per Employee	n/a
Profits Per Employee	-$886,642
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.81% in the last 52 weeks. The beta is 0.58, so PCSA's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-91.81%
50-Day Moving Average	1.13
200-Day Moving Average	1.63
Relative Strength Index (RSI)	35.58
Average Volume (20 Days)	935,934

Short Selling Information

The latest short interest is 71,556, so 2.19% of the outstanding shares have been sold short.

Short Interest	71,556
Short Previous Month	73,056
Short % of Shares Out	2.19%
Short % of Float	2.47%
Short Ratio (days to cover)	2.45

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.79M
Pretax Income	-9.83M
Net Income	-11.53M
EBITDA	-11.79M
EBIT	-11.79M
Earnings Per Share (EPS)	-$4.55

Full Income Statement

Balance Sheet

The company has $2.89 million in cash and $96,844 in debt, giving a net cash position of $2.79 million or $0.86 per share.

Cash & Cash Equivalents	2.89M
Total Debt	96,844
Net Cash	2.79M
Net Cash Per Share	$0.86
Equity (Book Value)	3.72M
Book Value Per Share	1.14
Working Capital	3.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.12 million and capital expenditures -$3,244, giving a free cash flow of -$11.12 million.

Operating Cash Flow	-11.12M
Capital Expenditures	-3,244
Free Cash Flow	-11.12M
FCF Per Share	-$3.41

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PCSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-117.51%
Shareholder Yield	-117.51%
Earnings Yield	-415.08%
FCF Yield	-400.61%

Analyst Forecast

The average price target for PCSA is $5.00, which is 488.24% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	488.24%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 22, 2024. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Jan 22, 2024
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1